Antibodies that neutralize oxidized fats to protect bone health
Antibodies against Oxidized Phospholipids and Osteoporosis
This project will see if boosting natural antibodies that neutralize oxidized phospholipids can help prevent age-related bone loss and osteoporosis.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Central Arkansas Veterans Hlthcare Sys NIH-funded |
| Lab location | 1 site (North Little Rock, United States) |
| Project ID | NIH-11264782 on NIH RePORTER |
What this research studies
You can learn about a harmful type of oxidized fat (oxidized phospholipids) that damages bone-forming cells and may drive osteoporosis. In mice, increasing a natural antibody called E06 protected bone mass and increased bone formation, so researchers are working to raise those antibody levels either genetically or by injections. They are studying effects on bone cells, bone-building pathways (like Wnt signaling), and overall bone mass using cell studies and sequencing techniques. The work aims to turn those findings into approaches that could someday prevent or reverse bone loss in people.
Who could benefit from this research
Good fit: Ideal candidates would be older adults with osteoporosis or progressive age-related bone loss who are interested in novel biologic approaches to protect bone.
Not a fit: People whose bone loss is due to unrelated genetic disorders, untreated hormonal imbalances, or conditions not driven by oxidized phospholipids may not benefit from this approach.
Why it matters
Potential benefit: If successful, this work could lead to a new therapy that protects bone-forming cells and reduces fracture risk from osteoporosis.
How similar studies have performed: Related experiments showed increased bone mass in mice with higher E06 antibody levels, but translating this approach to humans is still new.
Where this research is happening
North Little Rock, United States
- Central Arkansas Veterans Hlthcare Sys — North Little Rock, United States (Active)
Researchers
- Principal investigator: Ambrogini, Elena — Central Arkansas Veterans Hlthcare Sys
- Study coordinator: Ambrogini, Elena
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.